Currency effects and a decline in business from its North American and U.K. markets contributed to a 14.3% drop in sales for Agfa HealthCare in its second quarter.
For the period (end-June 30), the Greenville, SC-based vendor had sales of 313 million euros ($487.8 million U.S.), down from 365 million euros ($568.8 million U.S.) last year. The Agfa unit had recurring earnings before interest and taxes of 19.5 million euros ($30.4 million U.S.), down from 33.3 million euros ($51.8 million U.S.) a year ago.
The sales decrease was mainly attributable to North America and the U.K., where a strong euro affected the company's competitive position, Agfa said. In addition, the market-driven decline in its x-ray business is more pronounced in those markets and not compensated by healthcare IT, according to the vendor.
In quarterly highlights, Agfa said that its computed radiography segment performed well in the second quarter. The imaging IT segment also started to recover following its weak performance in the first quarter, the company said.
Related Reading
Agfa, Nexsan team up, July 28, 2008
Agfa taps new VP for IT, July 23, 2008
Agfa receives Premier contract, July 18, 2008
Agfa to add OrthoView to Impax, July 14, 2008
Report: Agfa talks possible sale with two companies, July 1, 2008
Copyright © 2008 AuntMinnie.com
